ZIM Laboratories (NSE:ZIMLAB, BOM:541400) consolidated profit attributable to the owners dropped to 37.4 million Indian rupees in the fiscal fourth quarter from 48.8 million rupees a year ago, according to an Indian bourse filing on Tuesday.
Shares of the company fell over 4% in Wednesday's trade.
Earnings per share for the quarter ended March 31 contracted to 0.76 rupees from 1.01 rupees a year earlier.
The pharmaceutical company's revenue from operations also slipped year on year to 1.05 billion rupees from 1.09 billion rupees, the filing said.